Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRTO | Ordinary Shares | Options Exercise | $105K | +10.2K | +34.37% | $10.34 | 39.9K | Feb 13, 2023 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRTO | Non-employee Warrant (right to buy) | Options Exercise | $0 | -10.2K | -100% | $0.00* | 0 | Feb 13, 2023 | Ordinary Shares | 10.2K | $10.34 | Direct | F1, F3, F4 |
Id | Content |
---|---|
F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
F2 | The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.34 using the exchange rate as of February 13, 2023 (1.00 = $0.933). |
F3 | For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). |
F4 | Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. Warrant is set to expire on March 6, 2023. |